Fortrea (NASDAQ:FTRE) Price Target Cut to $12.00 by Analysts at Barclays
Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...
Fortrea (NASDAQ:FTRE) Price Target Lowered to $11.00 at The Goldman Sachs Group
Fortrea (NASDAQ:FTRE – Get Free Report) had its target price decreased by analysts at The Goldman Sachs Group from $22.00 to ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Pharmaceutical Technology3h
Project Optimus: The evolution of dose optimisation in oncology
Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...